Indian Company Master Data Made Simple
Rossari Biotech Limited
Incorporated on 9 Aug 2009, Rossari Biotech Limited has been operating for 17 years. Rossari Biotech Limited holds the CIN L24100MH2009PLC194818 and registration number 194818. Rossari Biotech Limited is identified as company limited by shares in the corporate registry. The company’s authorized capital value is ₹12.00 crore. The company’s paid-up capital is ₹11.08 crore.
Mainly engaged in manufacture of chemicals and chemical products. Rossari Biotech Limited is officially registered in Mumbai. The company’s incorporation address is Rossari House, Golden Oak, Lbs Marg, Surya Nagar, Opp. Mahindra Showroom, Vikhroli (west), Mumbai, Mumbai, Mumbai, Maharashtra, India, 400079. The entity is active and conducting operations. Its registered PAN is AAECR4325G as per government records. Its LEI code is registered as 335800R7XFRR8ZTHBQ25. For correspondence, the registered email address is cs@rossari.com. The senior leadership includes Ketan Sablok (CFO) and Ketan Sablok (CFO).
Company Overview
- CIN
- Date of Incorporation
- 09/08/2009
- Company Status
- Active
- RoC
- Mumbai
- Registration Number
- Balance sheet date
- 31/03/2025
- Company Category
- Company limited by shares
- Company Sub Category
- Non-government company
- Listed in Stock Exchange
- Yes
- Class of Company
- Public Limited Company
- LEI Number
- LEI Status
- Issued
- Authorized Capital
- ₹12,00,00,000.00
- Paid up Capital
- ₹11,07,62,732.00
- Activity
- Manufacture Of Chemicals And Chemical Products
- cs@rossari.com
- PAN
GST Numbers
| State | GST Number | Status |
|---|---|---|
| Andhra Pradesh | 37AAECR4325G1ZG | Active |
| Assam | 18AAECR4325G1ZG | Active |
| Dadra and Nagar Haveli and Daman and Diu | 26AAECR4325G1ZJ | Active |
| Gujarat | 24AAECR4325G1ZN | Inactive |
| 24AAECR4325G2ZM | Active | |
| Haryana | 06AAECR4325G1ZL | Inactive |
| Karnataka | 29AAECR4325G1ZD | Inactive |
| Maharashtra | 27AAECR4325G1ZH | Active |
| 27AAECR4325G2ZG | Active | |
| Tamil Nadu | 33AAECR4325G1ZO | Inactive |
ISIN Numbers
| ISIN | Security | Interest Rate | Maturity Date | FISN | CFI |
|---|---|---|---|---|---|
| INE02A801020 | ROSSARI BIOTECH LIMITED EQ NEW FV RS. 2/- | - | 12/10/2026 | ROSSARI BIOTEC/SH VTG | ESVUFN |
| IN802A801011 | ROSSARI BIOTECH LIMITED EQ NEW FV RS. 2/- LISTING/TRDG APRVL AWAITED | - | 12/10/2026 | ROSSARI BIOTEC/SH VTG | ESVUFN |
Balance Sheet
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 |
|---|---|---|---|---|---|
| Net PPE | ₹75,561.20L | ₹55,572.50L | ₹42,512.20L | ₹33,445.70L | ₹0.00L |
| Net Debt | ₹33,267.90L | ₹14,377.10L | ₹8,065.70L | ₹473.00L | ₹0.00L |
| Goodwill | ₹11,871.10L | ₹11,871.10L | ₹11,871.10L | ₹11,871.10L | ₹0.00L |
| Gross PPE | ₹1,00,522.20L | ₹75,700.50L | ₹58,147.70L | ₹45,642.00L | ₹0.00L |
| Inventory | ₹40,454.50L | ₹35,508.00L | ₹28,232.60L | ₹18,847.80L | ₹0.00L |
| Total Debt | ₹43,593.70L | ₹21,799.80L | ₹11,879.20L | ₹7,392.80L | ₹0.00L |
| Common Stock | ₹1,107.70L | ₹1,107.30L | ₹1,104.90L | ₹1,103.10L | ₹0.00L |
| Current Debt | ₹31,366.00L | ₹8,794.10L | ₹7,250.30L | ₹3,899.50L | ₹0.00L |
| Share Issued | ₹553.83L | ₹553.64L | ₹552.46L | ₹551.55L | ₹0.00L |
| Total Assets | ₹2,28,879.20L | ₹1,89,618.40L | ₹1,57,215.10L | ₹1,36,756.50L | ₹0.00L |
| Capital Stock | ₹1,107.70L | ₹1,107.30L | ₹1,104.90L | ₹1,103.10L | ₹0.00L |
| Long Term Debt | ₹9,432.60L | ₹10,003.20L | ₹3,332.40L | ₹3,493.30L | ₹0.00L |
| Current Assets | ₹1,23,590.00L | ₹1,04,192.70L | ₹84,357.50L | ₹72,021.30L | ₹0.00L |
| Prepaid Assets | ₹14,059.20L | ₹9,263.80L | ₹6,370.20L | ₹2,634.90L | ₹0.00L |
| Working Capital | ₹44,634.20L | ₹50,535.50L | ₹41,883.80L | ₹37,170.50L | ₹0.00L |
| Invested Capital | ₹1,74,133.50L | ₹1,37,342.20L | ₹1,15,355.50L | ₹98,909.40L | ₹0.00L |
| Other Properties | ₹56,053.80L | ₹0.00L | ₹31,469.40L | ₹31,361.10L | ₹4,419.50L |
| Retained Earnings | ₹84,376.40L | ₹69,718.00L | ₹56,451.60L | ₹43,657.60L | ₹0.00L |
| Common Stock Equity | ₹1,33,334.90L | ₹1,18,544.90L | ₹1,04,772.80L | ₹91,516.60L | ₹0.00L |
| Net Tangible Assets | ₹1,10,943.60L | ₹94,063.80L | ₹78,486.60L | ₹64,053.40L | ₹0.00L |
| Tangible Book Value | ₹1,10,943.60L | ₹94,063.80L | ₹78,486.60L | ₹64,053.40L | ₹0.00L |
| Current Liabilities | ₹78,955.80L | ₹53,657.20L | ₹42,473.70L | ₹34,850.80L | ₹0.00L |
| Long Term Provisions | ₹826.00L | ₹0.00L | ₹398.40L | ₹449.00L | ₹291.80L |
| Stockholders Equity | ₹1,33,334.90L | ₹1,18,544.90L | ₹1,04,772.80L | ₹91,516.60L | ₹0.00L |
| Other Equity Interest | ₹546.90L | ₹219.00L | ₹353.60L | ₹350.30L | ₹0.00L |
| Total Capitalization | ₹1,42,767.50L | ₹1,28,548.10L | ₹1,08,105.20L | ₹95,009.90L | ₹0.00L |
| Ordinary Shares Number | ₹553.83L | ₹553.64L | ₹552.46L | ₹551.55L | ₹0.00L |
| Other Intangible Assets | ₹10,520.20L | ₹12,610.00L | ₹14,415.10L | ₹15,592.10L | ₹0.00L |
| Other Non Current Assets | ₹0.30L | ₹0.30L | ₹0.30L | ₹0.30L | ₹0.00L |
| Total Non Current Assets | ₹1,05,289.20L | ₹85,425.80L | ₹72,857.60L | ₹64,735.20L | ₹0.00L |
| Cash And Cash Equivalents | ₹7,530.70L | ₹4,420.20L | ₹2,517.00L | ₹6,919.80L | ₹0.00L |
| Construction In Progress | ₹19,507.40L | ₹20,219.00L | ₹11,042.80L | ₹2,084.60L | ₹0.00L |
| Accumulated Depreciation | -₹24,961.00L | -₹20,128.00L | -₹15,635.50L | -₹12,196.30L | ₹0.00L |
| Additional Paid In Capital | ₹47,317.80L | ₹47,508.20L | ₹46,862.70L | ₹46,405.60L | ₹0.00L |
| Other Short Term Investments | ₹3,762.40L | ₹6,085.40L | ₹4,433.40L | ₹7,929.90L | ₹0.00L |
| Machinery Furniture Equipment | ₹50,747.10L | ₹29,040.60L | ₹23,787.10L | ₹21,136.80L | ₹0.00L |
| Goodwill And Other Intangible Assets | ₹22,391.30L | ₹24,481.10L | ₹26,286.20L | ₹27,463.20L | ₹0.00L |
| Total Equity Gross Minority Interest | ₹1,33,334.90L | ₹1,18,544.90L | ₹1,04,772.80L | ₹91,516.60L | ₹0.00L |
| Total Liabilities Net Minority Interest | ₹95,544.30L | ₹71,073.50L | ₹52,442.30L | ₹45,239.90L | ₹0.00L |
| Current Debt And Capital Lease Obligation | ₹32,135.80L | ₹9,565.90L | ₹7,456.20L | ₹3,899.50L | ₹0.00L |
| Long Term Debt And Capital Lease Obligation | ₹11,457.90L | ₹12,233.90L | ₹4,423.00L | ₹3,493.30L | ₹0.00L |
| Cash Cash Equivalents And Short Term Investments | ₹11,293.10L | ₹10,505.60L | ₹6,950.40L | ₹14,849.70L | ₹0.00L |
| Total Non Current Liabilities Net Minority Interest | ₹16,588.50L | ₹17,416.30L | ₹9,968.60L | ₹10,389.10L | ₹0.00L |
Cash Flow
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| Net Income | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| Free Cash Flow | -₹19,960.40L | -₹2,106.90L | -₹8,802.80L | ₹11,868.20L |
| Changes In Cash | ₹3,190.90L | ₹1,864.90L | -₹4,377.40L | ₹3,151.90L |
| End Cash Position | ₹7,530.70L | ₹4,420.20L | ₹2,517.00L | ₹6,919.80L |
| Financing Cash Flow | ₹18,632.20L | ₹6,490.10L | ₹1,618.50L | ₹6,085.50L |
| Investing Cash Flow | -₹21,948.10L | -₹18,369.50L | -₹10,321.40L | -₹18,089.40L |
| Operating Cash Flow | ₹6,506.80L | ₹13,744.30L | ₹4,325.50L | ₹15,155.80L |
| Capital Expenditure | -₹26,467.20L | -₹15,851.20L | -₹13,128.30L | -₹3,287.60L |
| Beginning Cash Position | ₹4,420.20L | ₹2,517.00L | ₹6,919.80L | ₹3,747.70L |
| Issuance Of Capital Stock | ₹83.30L | ₹506.70L | ₹384.50L | ₹421.20L |
Income Statement
| Metric | 31/03/2026 | 31/03/2025 | 31/03/2024 | 31/03/2023 |
|---|---|---|---|---|
| EBIT | ₹23,105.80L | ₹20,299.60L | ₹19,698.70L | ₹16,653.40L |
| Ebit | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| EBITDA | ₹31,018.20L | ₹27,006.90L | ₹25,737.70L | ₹22,946.50L |
| Basic EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Net Income | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| Diluted EPS | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Gross Profit | ₹70,568.00L | ₹62,190.00L | ₹52,111.50L | ₹47,285.90L |
| Pretax Income | ₹20,251.50L | ₹18,518.50L | ₹17,761.50L | ₹14,421.90L |
| Tax Provision | ₹5,330.20L | ₹4,880.70L | ₹4,692.60L | ₹3,696.20L |
| Total Revenue | ₹2,38,981.80L | ₹2,07,145.70L | ₹1,82,518.80L | ₹1,65,131.70L |
| Cost Of Revenue | ₹1,68,413.80L | ₹1,44,955.70L | ₹1,30,407.30L | ₹1,17,845.80L |
| Total Expenses | ₹2,19,985.80L | ₹1,88,400.50L | ₹1,64,247.00L | ₹1,49,968.50L |
| Interest Income | ₹135.10L | ₹85.70L | ₹223.90L | ₹252.10L |
| Interest Expense | ₹2,854.30L | ₹1,781.10L | ₹1,937.20L | ₹2,231.50L |
| Operating Income | ₹18,996.00L | ₹18,745.20L | ₹18,271.80L | ₹15,163.20L |
| Tax Rate For Calcs | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Income Tax Expense | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Normalized EBITDA | ₹29,009.20L | ₹26,847.40L | ₹25,293.10L | ₹22,847.50L |
| Normalized Income | ₹13,441.07L | ₹13,520.34L | ₹12,741.76L | ₹10,652.07L |
| Operating Expense | ₹51,572.00L | ₹43,444.80L | ₹33,839.70L | ₹32,122.70L |
| Operating Revenue | ₹2,38,981.80L | ₹2,07,145.70L | ₹1,82,518.80L | ₹1,65,131.70L |
| Net Interest Income | -₹2,719.20L | -₹1,695.40L | -₹1,713.30L | -₹1,979.40L |
| Total Unusual Items | ₹2,009.00L | ₹159.50L | ₹444.60L | ₹99.00L |
| Basic Average Shares | ₹553.74L | ₹553.08L | ₹552.10L | ₹551.14L |
| Diluted Average Shares | ₹554.10L | ₹553.71L | ₹553.27L | ₹553.56L |
| Other Operating Expenses | ₹9,814.50L | ₹8,465.10L | ₹6,936.50L | ₹6,019.30L |
| Reconciled Depreciation | ₹7,912.40L | ₹6,707.30L | ₹6,039.00L | ₹6,293.10L |
| Total Operating Expenses | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Reconciled Cost Of Revenue | ₹1,68,413.80L | ₹1,44,955.70L | ₹1,30,407.30L | ₹1,17,845.80L |
| Rent Expense Supplemental | ₹1,543.70L | ₹775.20L | ₹670.00L | ₹532.20L |
| Tax Effect Of Unusual Items | ₹528.77L | ₹42.04L | ₹117.46L | ₹25.37L |
| Interest Income Non Operating | ₹135.10L | ₹85.70L | ₹223.90L | ₹252.10L |
| Selling And Marketing Expense | ₹10,563.50L | ₹9,474.70L | ₹6,435.60L | ₹6,750.30L |
| Interest Expense Non Operating | ₹2,854.30L | ₹1,781.10L | ₹1,937.20L | ₹2,231.50L |
| Net Income Common Stockholders | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| Net Income Continuous Operations | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| Diluted NIAvailto Com Stockholders | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| General And Administrative Expense | ₹3,270.10L | ₹2,802.20L | ₹1,697.30L | ₹1,533.50L |
| Selling General And Administration | ₹13,833.60L | ₹12,276.90L | ₹8,132.90L | ₹8,283.80L |
| Otherunder Preferred Stock Dividend | ₹0.00L | ₹0.00L | ₹0.00L | ₹0.00L |
| Total Unusual Items Excluding Goodwill | ₹2,009.00L | ₹159.50L | ₹444.60L | ₹99.00L |
| Net Non Operating Interest Income Expense | -₹2,719.20L | -₹1,695.40L | -₹1,713.30L | -₹1,979.40L |
| Net Income Including Noncontrolling Interests | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| Net Income From Continuing And Discontinued Operation | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
| Net Income From Continuing Operation Net Minority Interest | ₹14,921.30L | ₹13,637.80L | ₹13,068.90L | ₹10,725.70L |
Company Performance (FY23–FY26)
Directors
| Appointment | Director name | DIN | Designation | |
|---|---|---|---|---|
| 10/08/2009 | Edward Walter Menezes | 00149205 | Whole-time director | View other directorships |
| 26/09/2019 | Sunil Srinivasan Chari | 00149083 | Managing Director | View other directorships |
| 12/11/2019 | Aseem Dhru | 01761455 | Director | View other directorships |
| 18/11/2019 | Parul Gupta | *****6041Q | Company Secretary | |
| 29/04/2023 | Aparna Narendra Sharma | 07132341 | Director | View other directorships |
| 01/05/2023 | Ketan Sablok | *****2830M | CFO | |
| 21/10/2023 | Esha Padmanabhan Achan | 10350369 | Director | View other directorships |
| 19/10/2024 | Gurudas Vishwas Aras | 02187903 | Director | View other directorships |
Business Network
Directors 8
- Sunil Srinivasan ChariManaging Director
- Edward Walter MenezesWhole-time director
- Gurudas Vishwas ArasDirector
- Esha Padmanabhan AchanDirector
- Aparna Narendra SharmaDirector
- Aseem DhruDirector
- Ketan SablokCFO
- Parul GuptaCompany Secretary
Subsidiaries 1
- Unitop Chemicals Private LimitedDirect
Latest Documents
| Date | Title | Size |
|---|---|---|
| 16/10/2024 | Form MGT-7-16102024_signed | - |
| 21/09/2024 | Form AOC-4(XBRL)-21092024_signed | - |
| 27/03/2024 | Form Addendum to AOC-4 CSR-27032024_signed | - |
Charges
| SRN | Date | Amount | Holder |
|---|---|---|---|
| AB9178178 | 06/11/2025 | ₹89,50,000.00 | Bank Of Baroda |
| AB9005336 | 17/10/2025 | ₹1,20,00,000.00 | Bank Of Baroda |
| AA3247963 | 23/02/2023 | ₹25,00,00,000.00 | Standard Chartered Bank |
| AB8420741 | 12/10/2022 | ₹45,00,00,000.00 | Citi Bank N.a. |
| AA3247170 | 12/10/2022 | ₹50,00,00,000.00 | Citi Bank N.a. |
| AA7950406 | 15/10/2019 | ₹75,00,00,000.00 | Axis Bank Limited |
| AA3237987 | 07/05/2018 | ₹11,50,00,000.00 | State Bank Of India |
| R04858890 | 18/04/2017 | ₹95,71,000.00 | The Saraswat Co-op. Bank Limited |
| R04862934 | 18/04/2017 | ₹94,83,000.00 | The Saraswat Co-op. Bank Limited |
| R04864336 | 30/03/2017 | ₹5,26,000.00 | The Saraswat Co-op. Bank Limited |
| H47077334 | 30/03/2017 | ₹6,34,000.00 | The Saraswat Co-op. Bank Limited |
| R04865663 | 30/03/2017 | ₹20,54,000.00 | The Saraswat Co-op. Bank Limited |
| G72198021 | 01/03/2017 | ₹7,00,000.00 | The Saraswat Co-op. Bank Limited |
| AA3235772 | 27/07/2015 | ₹30,00,00,000.00 | The Hongkong And Shanghai Banking Corporation Limited |
| G78893849 | 12/12/2014 | ₹22,80,00,000.00 | Kotak Mahindra Bank Limited |
| C45723848 | 27/12/2012 | ₹10,40,00,000.00 | Ing Vysya Bank Limited |
| G75607499 | 13/04/2012 | ₹15,25,000.00 | The Saraswat Co-operative Bank Ltd |
| H42624676 | 25/12/2011 | ₹1,61,85,000.00 | Department Of Biotechnology |
| C46070348 | 28/09/2011 | ₹14,87,61,000.00 | Ing Vysya Bank Limited |
| G62216262 | 27/01/2010 | ₹13,40,00,000.00 | Axis Bank Limited |
| R74894478 | 02/12/2009 | ₹40,81,00,000.00 | Hdfc Bank Limited |
| AA3177146 | 02/12/2009 | ₹40,81,00,000.00 | Hdfc Bank Limited |
Similar Companies
| Company | CIN | Address |
|---|---|---|
| Genesis Ibrc India Limited | L24100AP1992PLC107068 | Survey No. 241/2 & 389/2, Dwaraka Tirumala Road, Denduluru Denduluru West Godavari Ap 534432 In |
| Jyotirgamya Enterprises Limited | L24100DL1986PLC234423 | Unit No. F01 A-23 Jdkd Corporate Park, Mohan Cooperative Industrial Estate, Badarpur (south Delhi), South Delhi, New Delhi, Delhi, India, 110044 |
| New Era Alkaloids And Exports Limited | L24100CT1994PLC008842 | 408, Wallfort Ozone, Fafadih, Raipur, Raipur, Chattisgarh, India, 492001 |
| Osian Industries Limited | L24100GJ1982PLC005302 | Shrimad Bhawan Off No. Sf 23, 3rd Floor, Opp Kanta Vika, S Gruh, Rajkot, Rajkot, Gujarat, India, 360002 |
| Sanco Industries Limited | L24100DL1989PLC035549 | D-161, Surajmal Vihar, East Delhi, Delhi, Delhi, India, 110092 |
Direct/Ultimate Children
| Type | Legal Name | LEI code |
|---|---|---|
| Direct | Unitop Chemicals Private Limited | 335800X7IM4CJOY6AE12 |
Address
Frequently Asked Questions
The current board member of Rossari Biotech Limited are:
- Aseem Dhru
- Parul Gupta
- Sunil Srinivasan Chari
- Edward Walter Menezes
- Gurudas Vishwas Aras
- Esha Padmanabhan Achan
- Aparna Narendra Sharma
- Ketan Sablok